开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-10-23 ms2000001734084726 来自山西省

投稿命中率:75.0
偏重的研究方向：胃肠外科
经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-12-24 ms3000001457012474 来自贵州省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：泌尿系统肿瘤
经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-09-20 ms5000001759563327 来自重庆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：腹腔镜临床;腔镜手术
经验分享：想问一下大家proof之后多久交版面费已经过了14天了

76 0

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-03-22 黄铭滨来自福建省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：腔镜手术;内镜;胃肠外科
经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多

101 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-04-15 ms4000000274300101

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：腔镜手术;胃肠外科
经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。

94 0

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-03-31 ms6000001755812158 来自湖北省

偏重的研究方向：胃肠外科
经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof

77 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2018-06-18 ebetheone

你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表:
刚发了一篇.一审10天.修改20天.返修10天接收.很快.

奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.

285 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-07-27 m414297222

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2020-1-10submission 2020-1-27accepted

210 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-02-03 ms6000001755812158 来自湖北省

提交第二天就under review 应该是编辑在审

97 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2164476, encodeId=269d21644e60c, content=投稿命中率:75.0 偏重的研究方向：胃肠外科 经验分享：没想到投稿20天就接受了，中间没有修改，请问后续直接校样了是吗？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dac78495921, createdName=ms2000001734084726, createdTime=Mon Oct 23 21:42:19 CST 2023, time=2023-10-23, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2176872, encodeId=ed7221e687272, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：泌尿系统肿瘤 经验分享：期刊审稿还是很快的，但是想问问大家，我之前选的是OA，后面校稿过程中可以重新选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bca6479745, createdName=ms3000001457012474, createdTime=Sun Dec 24 16:07:31 CST 2023, time=2023-12-24, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2158732, encodeId=87c72158e32e1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：腹腔镜临床;腔镜手术 经验分享：想问一下大家proof之后多久交版面费已经过了14天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfc05644311, createdName=ms5000001759563327, createdTime=Wed Sep 20 16:11:22 CST 2023, time=2023-09-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2121226, encodeId=a96f2121226bf, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;内镜;胃肠外科 经验分享：1.10 submit 2.19 minor revision 2.28 resubmit 3.20 accept 整体审稿速度中等偏快，分数不高但是还算稳定。编辑很好，有问题及时提出，中间因为reference作者的数量问题耽误了一天。审稿人的问题比较简单，点对点回答就可以了，修改的部分也不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqjdzm6yCsj4z72SxHPAVVY9y7TBuXzTPGUuWxshXnm9Sp4MvDibYxoJje2aZc5J3iaqeibHHPIKOib7g/132, createdBy=fecc2546062, createdName=黄铭滨, createdTime=Wed Mar 22 23:06:49 CST 2023, time=2023-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2126124, encodeId=dd26212612419, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：腔镜手术;胃肠外科 经验分享：虽然感觉自己的文章创新性还可以，但临床意义不是太大。但没想到投稿后5天就接受了。感觉受宠若惊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86908099098, createdName=ms4000000274300101, createdTime=Sat Apr 15 21:17:42 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2122901, encodeId=79de21229019f, content=偏重的研究方向：胃肠外科 经验分享：想问问大家，accept之后，提交完copyright多久可以收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Mar 31 09:21:30 CST 2023, time=2023-03-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=558076, encodeId=421f5580e699, content=你好.请问接收后proof大概多久能有?奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804814, encodeId=a3c5804814a0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2020-1-10submission 2020-1-27accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIQMh5jMlvAibkVyDXOqwvbsicXibGz4JKG4vvKy81kYq8jSFxGOWAlFqFMWvbOFqt64ibxIUWFTicLeCw/132, createdBy=c12c1661090, createdName=m414297222, createdTime=Mon Jul 27 23:42:49 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112932, encodeId=5bb12112932dd, content=提交第二天就under review 应该是编辑在审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693a8510672, createdName=ms6000001755812158, createdTime=Fri Feb 03 21:39:11 CST 2023, time=2023-02-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1093490, encodeId=a4e31093490dc, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

期刊可以有几个通讯作者/第一作者？

110 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务